Chuck Royce's PROF Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 990,348 shares of Profound Medical Corp. (PROF) worth $7.77 M, representing 0.08% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in PROF, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2020, adding 291,000 shares. Largest reduction occurred in Q3 2020, reducing 283,000 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Profound Medical (PROF) Holding Value Over Time
Track share changes against reported price movement
Quarterly Profound Medical (PROF) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +130,442 | Add 15.17% | 990,348 | $7.85 |
| Q3 2025 | +95,000 | Add 12.42% | 859,906 | $4.89 |
| Q2 2025 | +3,107 | Add 0.41% | 764,906 | $5.95 |
| Q1 2025 | -3,000 | Reduce 0.39% | 761,799 | $5.71 |
| Q4 2024 | +195,501 | Add 34.34% | 764,799 | $7.51 |
| Q3 2024 | +3,500 | Add 0.62% | 569,298 | $7.96 |
| Q2 2024 | +1,500 | Add 0.27% | 565,798 | $8.57 |
| Q4 2023 | -5,600 | Reduce 0.98% | 564,298 | $8.38 |
| Q3 2023 | +3,900 | Add 0.69% | 569,898 | $10.03 |
| Q2 2023 | -5,100 | Reduce 0.89% | 565,998 | $12.81 |
| Q1 2023 | +22,900 | Add 4.18% | 571,098 | $9.27 |
| Q4 2022 | +103,300 | Add 23.22% | 548,198 | $10.69 |
| Q3 2022 | -58,000 | Reduce 11.53% | 444,898 | $4.05 |
| Q2 2022 | -2,100 | Reduce 0.42% | 502,898 | $7.30 |
| Q1 2022 | -61,500 | Reduce 10.86% | 504,998 | $9.00 |
| Q4 2021 | +48,898 | Add 9.45% | 566,498 | $11.27 |
| Q3 2021 | +41,000 | Add 8.60% | 517,600 | $14.60 |
| Q2 2021 | +18,200 | Add 3.97% | 476,600 | $16.29 |
| Q1 2021 | +157,400 | Add 52.29% | 458,400 | $20.05 |
| Q4 2020 | +291,000 | Add 2910.00% | 301,000 | $20.57 |
| Q3 2020 | -283,000 | Reduce 96.59% | 10,000 | $17.60 |
| Q1 2020 | +98,000 | Add 50.26% | 293,000 | $9.62 |
| Q4 2019 | +195,000 | New Buy | 195,000 | $11.36 |
Chuck Royce's Profound Medical Investment FAQs
Chuck Royce first purchased Profound Medical Corp. (PROF) in Q4 2019, acquiring 195,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Profound Medical Corp. (PROF) for 25 quarters since Q4 2019.
Chuck Royce's largest addition to Profound Medical Corp. (PROF) was in Q4 2020, adding 301,000 shares worth $6.19 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 990,348 shares of Profound Medical Corp. (PROF), valued at approximately $7.77 M.
As of the Q4 2025 filing, Profound Medical Corp. (PROF) represents approximately 0.08% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Profound Medical Corp. (PROF) was 990,348 shares, as reported at the end of Q4 2025.